Related Experiment Videos
Sodium cromoglycate in nocturnal asthma
Thorax
|January 1, 1986
Summary
This study investigated sodium cromoglycate for nocturnal asthma. It found that while it improved oxygen levels, it did not reduce overnight bronchoconstriction, suggesting mast cell degranulation is not key to nocturnal asthma.
Area of Science:
- Pulmonary Medicine
- Allergy and Immunology
- Respiratory Physiology
Background:
- Nocturnal asthma significantly impacts patient quality of life.
- The role of mast cell degranulation in nocturnal asthma pathogenesis remains unclear.
- Understanding triggers for overnight bronchoconstriction is crucial for effective treatment.
Purpose of the Study:
- To determine if mast cell degranulation contributes to nocturnal asthma.
- To evaluate the efficacy of sodium cromoglycate in managing overnight asthma symptoms.
- To assess the impact of sodium cromoglycate on bronchoconstriction and oxygenation during sleep.
Main Methods:
- A double-blind, placebo-controlled crossover study was conducted.
- Eight patients with nocturnal wheeze received a single high dose of nebulised sodium cromoglycate or placebo.
- Overnight measurements included forced expiratory volume in 1 second (FEV1), forced vital capacity (FVC), oxygen saturation, and breathing patterns.
Main Results:
- Sodium cromoglycate treatment did not significantly reduce the overnight decline in FEV1 or FVC.
- A notable improvement in nocturnal oxygen saturation was observed with sodium cromoglycate.
- Breathing patterns were also monitored, though specific changes were not detailed in the abstract.
Conclusions:
- Mast cell degranulation may not play a primary role in the development of nocturnal asthma.
- Sodium cromoglycate's lack of effect on bronchoconstriction suggests alternative pathways are involved.
- Further research is needed to elucidate the mechanisms driving nocturnal asthma and to identify more effective therapeutic targets.